Molecules 2011, 16(1), 281-290; doi:10.3390/molecules16010281
Article

An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication

1 Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182, USA 2 Department of Chemistry and Biochemistry, University of California, La Jolla, San Diego, CA 92093, USA
* Authors to whom correspondence should be addressed.
Received: 15 November 2010; in revised form: 24 December 2010 / Accepted: 28 December 2010 / Published: 30 December 2010
PDF Full-text Download PDF Full-Text [172 KB, uploaded 30 December 2010 15:15 CET]
Abstract: A class of dihydropyranobenzimidazole inhibitors was recently discovered that acts against the hepatitis C virus (HCV) in a new way, binding to the IRES-IIa subdomain of the highly conserved 5' untranslated region of the viral RNA and thus preventing the ribosome from initiating translation. However, the reported synthesis of these compounds is lengthy and low-yielding, the intermediates are troublesome to purify, and the route is poorly structured for the creation of libraries. We report a streamlined route to this class of inhibitors in which yields are far higher and most intermediates are crystalline. In addition, a key variable side chain is introduced late in the synthesis, allowing analogs to be easily synthesized for optimization of antiviral activity.
Keywords: HCV; benzimidazole; RNA; replication; inhibitor

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Parker, M.A.; Satkiewicz, E.; Hermann, T.; Bergdahl, B.M. An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication. Molecules 2011, 16, 281-290.

AMA Style

Parker MA, Satkiewicz E, Hermann T, Bergdahl BM. An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication. Molecules. 2011; 16(1):281-290.

Chicago/Turabian Style

Parker, Matthew A.; Satkiewicz, Emily; Hermann, Thomas; Bergdahl, B. Mikael. 2011. "An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication." Molecules 16, no. 1: 281-290.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert